FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310063745> ?p ?o ?g. }

• W4310063745 endingPage "154567" @default.
• W4310063745 startingPage "154567" @default.
• W4310063745 abstract "Colorectal cancer (CRC) is one of the most commonly diagnosed cancers with high metastasis and lethality. Arrestin domain-containing 4 (ARRDC4) is involved in inhibiting cancer glycolytic phenotypes. Brusatol (BR), extracted from Bruceae Fructus, exerts good anti-cancer effects against a number of cancers. In the present study, we aimed to explore the efficacy of BR on inhibiting CRC metastasis and elucidate the underlying mechanisms involving the upregulation of the ARRDC4 expression. Cell viability, colony formation, wound healing and transwell assay were used to detect the anti-proliferative and anti-metastatic effects of BR against CRC in vitro. Microarray analysis was performed to find out differential genes in CRC cells after treatment with BR. Analysis of the CRC patients tumor samples and GEPIA database were first conducted to identify the expression of ARRDC4 on CRC. Stable overexpression and knockdown of ARRDC4 CRC cells were established by lentiviral transfection. The role of ARRDC4 in mediating the anti-metastatic effects of BR on CRC was measured using qRT-PCR, western blotting, immunohistochemical and immunofluorescence analysis. Orthotopic xenograft and pulmonary metastasis mouse models of CRC were established to determine the anti-cancer and anti-metastatic effects of ARRDC4 and BR. BR markedly suppressed the cell proliferation, migration, invasion and inhibited tumor growth and tumor metastasis. Microarray analysis demonstrated that BR treatment markedly increased the gene expression of ARRDC4 in CRC cells. ARRDC4 was significantly repressed in CRC in the clinical samples and GEPIA analysis. ARRDC4 overexpression plus BR produced better inhibitory effects on CRC metastasis than BR treatment alone, while ARRDC4 knockdown could partially eliminate the inhibitory effects of BR against CRC metastasis. BR exerted anti-metastatic effects against CRC via upregulating ARRDC4 and inhibiting epithelial-mesenchymal transition (EMT) processing through modulating PI3K/Hippo pathway. This study reported for the first time that BR is a potent ARRDC4 agonist, and is worthy of further development into a new therapeutic strategy for CRC." @default.
• W4310063745 created "2022-11-30" @default.
• W4310063745 creator A5004560402 @default.
• W4310063745 creator A5008712473 @default.
• W4310063745 creator A5045703368 @default.
• W4310063745 creator A5045818295 @default.
• W4310063745 creator A5049313911 @default.
• W4310063745 creator A5051090963 @default.
• W4310063745 creator A5060426525 @default.
• W4310063745 creator A5081004832 @default.
• W4310063745 date "2023-01-01" @default.
• W4310063745 modified "2023-10-11" @default.
• W4310063745 title "Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway" @default.
• W4310063745 cites W1531523780 @default.
• W4310063745 cites W1601583906 @default.
• W4310063745 cites W1836480625 @default.
• W4310063745 cites W1965498876 @default.
• W4310063745 cites W1966133006 @default.
• W4310063745 cites W1967176992 @default.
• W4310063745 cites W1972316552 @default.
• W4310063745 cites W1998778049 @default.
• W4310063745 cites W2003657787 @default.
• W4310063745 cites W2010414816 @default.
• W4310063745 cites W2061356851 @default.
• W4310063745 cites W2077950988 @default.
• W4310063745 cites W2100840394 @default.
• W4310063745 cites W2110845720 @default.
• W4310063745 cites W2129480424 @default.
• W4310063745 cites W2159196011 @default.
• W4310063745 cites W2332965161 @default.
• W4310063745 cites W2341760676 @default.
• W4310063745 cites W2555679923 @default.
• W4310063745 cites W2612222508 @default.
• W4310063745 cites W2745122750 @default.
• W4310063745 cites W2791593582 @default.
• W4310063745 cites W2793149794 @default.
• W4310063745 cites W2800059972 @default.
• W4310063745 cites W2808893718 @default.
• W4310063745 cites W2889835308 @default.
• W4310063745 cites W2897608968 @default.
• W4310063745 cites W2901068426 @default.
• W4310063745 cites W2905933524 @default.
• W4310063745 cites W2917964400 @default.
• W4310063745 cites W2949022836 @default.
• W4310063745 cites W2952842834 @default.
• W4310063745 cites W2970147023 @default.
• W4310063745 cites W2974147039 @default.
• W4310063745 cites W2986040377 @default.
• W4310063745 cites W3027265298 @default.
• W4310063745 cites W3038784387 @default.
• W4310063745 cites W3041026090 @default.
• W4310063745 cites W3083268343 @default.
• W4310063745 cites W3106751349 @default.
• W4310063745 cites W3128646645 @default.
• W4310063745 cites W3137945121 @default.
• W4310063745 cites W3138471173 @default.
• W4310063745 cites W3171164709 @default.
• W4310063745 cites W3174340849 @default.
• W4310063745 cites W3194675705 @default.
• W4310063745 cites W3204209694 @default.
• W4310063745 cites W4211233744 @default.
• W4310063745 doi "https://doi.org/10.1016/j.phymed.2022.154567" @default.
• W4310063745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36610120" @default.
• W4310063745 hasPublicationYear "2023" @default.
• W4310063745 type Work @default.
• W4310063745 citedByCount "2" @default.
• W4310063745 countsByYear W43100637452023 @default.
• W4310063745 crossrefType "journal-article" @default.
• W4310063745 hasAuthorship W4310063745A5004560402 @default.
• W4310063745 hasAuthorship W4310063745A5008712473 @default.
• W4310063745 hasAuthorship W4310063745A5045703368 @default.
• W4310063745 hasAuthorship W4310063745A5045818295 @default.
• W4310063745 hasAuthorship W4310063745A5049313911 @default.
• W4310063745 hasAuthorship W4310063745A5051090963 @default.
• W4310063745 hasAuthorship W4310063745A5060426525 @default.
• W4310063745 hasAuthorship W4310063745A5081004832 @default.
• W4310063745 hasConcept C104317684 @default.
• W4310063745 hasConcept C121608353 @default.
• W4310063745 hasConcept C126322002 @default.
• W4310063745 hasConcept C127561419 @default.
• W4310063745 hasConcept C150194340 @default.
• W4310063745 hasConcept C173396325 @default.
• W4310063745 hasConcept C193270364 @default.
• W4310063745 hasConcept C2779013556 @default.
• W4310063745 hasConcept C502942594 @default.
• W4310063745 hasConcept C526805850 @default.
• W4310063745 hasConcept C54355233 @default.
• W4310063745 hasConcept C55493867 @default.
• W4310063745 hasConcept C62112901 @default.
• W4310063745 hasConcept C62478195 @default.
• W4310063745 hasConcept C71924100 @default.
• W4310063745 hasConcept C81885089 @default.
• W4310063745 hasConcept C8415881 @default.
• W4310063745 hasConcept C86554907 @default.
• W4310063745 hasConcept C86803240 @default.
• W4310063745 hasConcept C95444343 @default.
• W4310063745 hasConceptScore W4310063745C104317684 @default.
• W4310063745 hasConceptScore W4310063745C121608353 @default.

• next